Insider trades
Rebecca Taub, Director of Madrigal Pharmaceuticals MDGL, has filed 0 purchases and 91 sales on the open market. Over the past 12 months that comes to a net sale of $21.7M. The latest trade was on 06/17.
Rebecca Taub
Director
- First filing
- 23/01/18
- Trades
- 125 trades
- Buys / sales
- 0 / 91
- 12-month net buying
- −$21.7M
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/06 | 03/06 | 491 sh | $431.94 | $212,082.54 | −0.1% | |
| Open-market sale | 01/26 | 01/26 | 647 sh | $492.42 | $318,595.74 | −0.1% | |
| Open-market sale | 01/20 | 01/20 | 2,238 sh | $490.77 | $1,098,343.26 | −0.5% | |
MDGL | Open-market sale10b5-1 plan | 01/09 | 01/13 | 18,650 sh30 trades | $522.76avg. | $9,749,384.66 | −3.9% |
MDGL | Open-market sale10b5-1 plan | 25/12/10 | 25/12/12 | 18,650 sh9 trades | $552.15avg. | $10,297,601.5 | −3.9% |
MDGL | Open-market sale10b5-1 plan | 25/08/11–25/08/12 | 25/08/13 | 46,463 sh12 trades | $355.31avg. | $16,508,952.94 | −9.2% |
| Open-market sale10b5-1 plan | 25/07/18 | 25/07/22 | 1,000 sh | $350.01 | $350,010 | −0.2% | |
MDGL | Open-market sale10b5-1 plan | 25/07/16–25/07/17 | 25/07/18 | 29,101 sh9 trades | $353.19avg. | $10,278,079.69 | −5.9% |
| Open-market sale | 25/01/24 | 25/01/27 | 648 sh | $335.24 | $217,235.52 | −0.1% | |
| Open-market sale | 25/01/17 | 25/01/17 | 1,689 sh | $273.41 | $461,789.49 | −0.4% | |
MDGL | Open-market sale10b5-1 plan | 24/04/08 | 24/04/10 | 2,676 sh6 trades | $245.99avg. | $658,263.87 | −0.6% |
MDGL | Open-market sale10b5-1 plan | 24/04/03–24/04/05 | 24/04/05 | 73,888 sh19 trades | $243.92avg. | $18,022,641.29 | −13.9% |